From October 26-29, 2023, the 28th Asia-Pacific Blood and Marrow Transplantation Conference (APBMT 2023) will be held in Semarang, Indonesia, in a hybrid online and offline format. As a highly anticipated event in the field of blood transplantation, the APBMT annual meeting invites experts and scholars in blood and marrow transplantation from across Asia and around the world to share and discuss the latest advancements and breakthroughs in the field, empowering clinical practice innovation and propelling the discipline towards innovative development.

Hematopoietic stem cell transplantation has been a focal discipline for GoBroad Healthcare Group since its inception. Under the leadership of experts Wu Tong, Wang Chun, and Li Chunfu, who boast over 30 years of transplantation experience, the GoBroad team has consistently upheld the philosophy of "patient needs first." By breaking through the "ceiling" of traditional treatments with innovative thinking and refining strategies to revitalize classic approaches, the team continuously expands the therapeutic boundaries of hematopoietic stem cell transplantation, advancing treatment details, and striving to extend the lives of patients with precise, effective, and compassionate medical services.

Committed to innovation for life and never halting progress, as a young force in the field of hematology, the GoBroad team has presented its research findings hundreds of times at international academic conferences such as EHA, ASH, EBMT, ASCO, etc. At this edition of the APBMT conference, the team from GoBroad Medical (Hematology) Beijing Research Center, Beijing GoBroad Boren Hospital, had 5 research achievements successfully selected, including 1 invited report, 2 conference speeches, and 2 poster presentations. From clinical treatment to nursing experience, the team shared advanced concepts, exploration, and practice in all aspects, once again contributing Chinese wisdom to the world and sharing innovative results globally.

These  research achievements selected for the conference are a testament to the GoBroad Boren Hospital team's relentless pursuit of innovation in the field of hematopoietic stem cell transplantation. Focusing on the complex challenges of the new era and the urgent treatment needs of patients, the GoBroad Boren team continuously optimizes and expands the therapeutic boundaries of transplantation methods in clinical treatment, tirelessly explores innovative applications of new therapies like CAR-T, and strives for excellence to enhance treatment outcomes. In nursing services, the GoBroad Boren team meticulously implements patient needs into every cutting-edge thought and exploration, always practicing compassionate care from the "heart" and alongside "love," deepening professional expertise and warming services, ultimately benefiting more patients. This embodies the GoBroad Boren team's consistent academic purpose and goal.